CX3CL1 and interstitial lung disease: The results obtained demonstrated that CX3CL1+ and CX3CR1+ cells localized to fibroblastic foci in SKG-ILD and that the anti-CX3CL1 mAb treatment reduced the number of M1 macrophages in BALF.